…
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Jamieson Wellness Inc. is a Canadian maker and distributor of vitamins, minerals and natural health products sold under the Jamieson brand and via private-label and export channels. Long-term growth may be driven by aging demographics, rising preventive-health demand and greater e-commerce and international penetration, while its manufacturing footprint and brand recognition could support steady cash generation.
Principal risks are regulatory changes to natural health-product rules, strong competition from multinationals and private labels, and execution risks from supply-chain disruptions, input-cost pressure and cross-border expansion that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 89.84M | 75.80M | 65.67M | 70.50M | 70.47M |
| Minority interest | -2.03M | 0.78M | 1.84M | - | - |
| Net income | 62.44M | 51.91M | 47.88M | 52.81M | 52.08M |
| Selling general administrative | 224.57M | 181.76M | 146.17M | 115.15M | 86.41M |
| Gross profit | 338.33M | 275.61M | 233.56M | 198.34M | 162.44M |
| Reconciled depreciation | 19.66M | 18.53M | 20.32M | 17.25M | 14.27M |
| Ebit | 113.76M | 96.07M | 87.39M | 83.19M | 76.03M |
| Ebitda | 133.42M | 114.60M | 102.88M | 100.44M | 90.30M |
| Depreciation and amortization | 19.66M | 18.53M | 20.32M | 17.25M | 14.27M |
| Operating income | 113.76M | 106.28M | 87.39M | 83.19M | 76.03M |
| Other operating expenses | 708.30M | 627.50M | 588.78M | 464.18M | 375.00M |
| Interest expense | 25.84M | 20.27M | 22.78M | 12.42M | 5.66M |
| Tax provision | 25.37M | 24.66M | 19.63M | 17.70M | 18.38M |
| Interest income | - | 30.48M | 29.58M | 12.69M | 5.57M |
| Net interest income | -22.41M | -20.27M | -22.78M | -12.42M | -5.66M |
| Income tax expense | 25.37M | 24.66M | 19.63M | 17.70M | 18.38M |
| Total revenue | 822.06M | 733.78M | 676.17M | 547.37M | 451.03M |
| Total operating expenses | 224.57M | 169.33M | 588.78M | 115.15M | 86.41M |
| Cost of revenue | 483.72M | 458.17M | 442.61M | 349.03M | 288.59M |
| Total other income expense net | -23.92M | -30.48M | 1.07M | -12.69M | -5.57M |
| Net income from continuing ops | 64.46M | 51.13M | 46.04M | 52.81M | 52.08M |
| Net income applicable to common shares | - | 51.91M | 47.88M | 52.81M | 52.08M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1215.03M | 1208.79M | 1143.57M | 1107.26M | 652.48M |
| Intangible assets | 362.75M | 377.21M | 366.52M | 367.20M | 192.68M |
| Other current assets | 7.79M | 6.80M | 9.04M | 10.88M | 7.18M |
| Total liab | 685.52M | 660.41M | 662.38M | 675.67M | 310.45M |
| Total stockholder equity | 485.42M | 505.18M | 438.93M | 431.59M | 342.02M |
| Other current liab | 76.49M | 30.66M | 7.55M | 26.04M | 25.70M |
| Common stock | 333.35M | - | 312.59M | 307.20M | 268.21M |
| Capital stock | 333.35M | 326.22M | 312.59M | 307.20M | 268.21M |
| Retained earnings | 90.37M | 99.11M | 80.65M | 85.48M | 59.00M |
| Other liab | - | - | - | 95.63M | 56.84M |
| Good will | 279.64M | 287.50M | 274.41M | 272.92M | 122.97M |
| Other assets | - | - | - | 3.03M | 2.70M |
| Cash | 41.23M | 44.79M | 36.86M | 26.24M | 6.78M |
| Total current liabilities | 174.15M | 172.68M | 145.33M | 154.81M | 83.62M |
| Current deferred revenue | - | - | 53.78M | - | - |
| Net debt | 430.80M | 263.50M | 426.12M | 373.76M | 142.35M |
| Short term debt | 4.14M | - | 7.55M | 0.00M | 0.00M |
| Short long term debt total | 472.02M | - | 462.99M | 400.00M | 149.12M |
| Other stockholder equity | 27.49M | - | 33.79M | 17.11M | 14.79M |
| Property plant equipment | - | - | - | 111.71M | 96.98M |
| Total current assets | 451.34M | 436.94M | 392.86M | 352.40M | 237.15M |
| Net tangible assets | - | - | - | -208.53M | 26.37M |
| Short term investments | - | - | 3.29M | - | - |
| Net receivables | 199.25M | 227.26M | 164.50M | 160.80M | 104.19M |
| Long term debt | 414.60M | 308.29M | 325.00M | 400.00M | 149.12M |
| Inventory | 203.08M | 154.66M | 182.46M | 154.49M | 119.01M |
| Accounts payable | 93.51M | 124.84M | 76.46M | 128.77M | 57.92M |
| Accumulated other comprehensive income | 34.20M | - | 11.89M | 21.79M | 0.02M |
| Non currrent assets other | - | - | 2.88M | - | - |
| Non current assets total | 763.69M | 771.85M | 750.71M | 754.86M | 415.33M |
| Long term debt total | - | - | - | 461.93M | 170.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -10.16M | -35.13M | -256.53M | -22.28M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -22.25M | -10.16M | -35.13M | -256.53M | -22.28M |
| Net borrowings | 100.70M | -22.27M | -79.54M | 247.54M | -3.14M |
| Total cash from financing activities | -62.78M | -45.43M | 14.04M | 225.41M | -16.51M |
| Change to operating activities | - | - | - | -27.01M | -27.33M |
| Net income | 62.44M | 51.13M | 46.04M | 52.81M | 52.08M |
| Change in cash | -3.56M | 7.92M | 10.62M | 19.46M | 5.61M |
| Begin period cash flow | 44.79M | 36.86M | 26.24M | 6.78M | 1.17M |
| End period cash flow | 41.23M | 44.79M | 36.86M | 26.24M | 6.78M |
| Total cash from operating activities | 82.51M | 61.58M | 31.71M | 50.59M | 44.41M |
| Issuance of capital stock | - | 0.00M | 84.58M | - | - |
| Depreciation | 19.66M | 18.53M | 20.32M | 17.25M | 14.27M |
| Other cashflows from investing activities | -8.69M | -0.98M | -0.47M | -242.60M | -0.79M |
| Dividends paid | 37.18M | -33.46M | -30.26M | 26.32M | 22.11M |
| Change to inventory | -48.42M | 27.80M | -14.27M | - | - |
| Change to account receivables | 21.44M | -63.53M | -3.70M | - | - |
| Sale purchase of stock | -139.44M | -0.95M | -29.00M | 4.19M | 8.73M |
| Other cashflows from financing activities | -5.61M | 11.25M | 152.84M | 343.58M | 81.62M |
| Change to netincome | - | - | - | 7.54M | 5.38M |
| Capital expenditures | 12.71M | 10.16M | 9.31M | 14.57M | 22.28M |
| Change in working capital | -17.90M | -31.17M | -32.13M | -27.01M | -27.33M |
| Stock based compensation | 8.22M | 7.12M | 5.65M | 4.76M | 5.48M |
| Other non cash items | 13.95M | 11.67M | -9.94M | 1.12M | 0.38M |
| Free cash flow | 69.80M | 51.41M | 22.41M | 36.02M | 22.12M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| JWEL Jamieson Wellness Inc |
0.04 0.09% |
45.60 | 23.71 | 16.29 | 1.72 | 2.95 | 2.20 | 13.69 |
| SAP Saputo Inc |
0.34 0.83% |
41.44 | 24.58 | 16.86 | 0.82 | 2.33 | 0.98 | 11.53 |
| PBH Premium Brands Holdings Corporation |
1.19 1.61% |
74.98 | 94.79 | 13.44 | 0.59 | 2.66 | 1.04 | 15.32 |
| MFI Maple Leaf Foods Inc. |
0.03 0.11% |
27.35 | 87.71 | 18.83 | 0.95 | 2.82 | 1.23 | 11.26 |
| HLF High Liner Foods Incorporated |
0.02 0.07% |
26.83 | 8.28 | 8.19 | 0.38 | 0.70 | 0.57 | 6.53 |
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Pilato | Pres, CEO & Director | 1975 |
| Mr. Christopher Snowden | CFO & Corp. Sec. | NA |
| Ms. Regan Stewart | Chief Operations & People Officer | NA |
| Mr. John Doherty | Chief Science & Innovation Officer | 1973 |
| Mr. Don Bird | Exec. VP of USA & Global Strategic Partners | 1964 |
| Ruth Winker | Corp. Communications Director | NA |
| Mr. Eric Bentz | Sr. VP of Global Marketing & MD of China | NA |
| Mr. Paul Galbraith | Sr. VP & MD of Canada | NA |
| Mr. Joel Scales | Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce | NA |
| Mr. Michael Pilato | President, CEO & Director | 1975 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.